Atif J Khan Selected Research

Glioblastoma (Glioblastoma Multiforme)

4/2019

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atif J Khan Research Topics

Disease

39	Breast Neoplasms (Breast Cancer) 10/2022 - 04/2002
27	Neoplasms (Cancer) 01/2022 - 09/2005
4	Neoplasm Metastasis (Metastasis) 02/2020 - 12/2016
4	Brain Neoplasms (Brain Tumor) 11/2018 - 04/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2013
3	Infections 07/2020 - 09/2009
2	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 04/2002
2	Cicatrix (Scar) 01/2020 - 06/2017
2	Fatigue 01/2020 - 09/2011
2	Glioma (Gliomas) 04/2019 - 05/2018
2	Medulloblastoma 10/2017 - 12/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2017 - 02/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 01/2014
2	Cardiotoxicity 01/2014 - 01/2014
1	Triple Negative Breast Neoplasms 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Mastodynia 12/2021
1	COVID-19 07/2020
1	Hypersensitivity (Allergy) 01/2020
1	Lymphedema (Milroy Disease) 01/2020
1	Pain (Aches) 01/2020
1	Inflammatory Breast Neoplasms 07/2019
1	Glioblastoma (Glioblastoma Multiforme) 04/2019
1	Carcinoma (Carcinomatosis) 02/2017
1	Central Nervous System Neoplasms 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2016
1	Hodgkin Disease (Hodgkin's Disease) 08/2014
1	Necrosis 06/2014
1	Unilateral Breast Neoplasms 01/2014
1	Wounds and Injuries (Trauma) 04/2013
1	Dermatitis 01/2012
1	Hyperpigmentation 01/2012
1	Melanoma (Melanoma, Malignant) 04/2011
1	Wound Infection (Wound Infections) 09/2009
1	Vomiting 01/2009
1	Nausea 01/2009
1	Ductal Carcinoma 11/2008
1	Fibrosis (Cirrhosis) 09/2005
1	Lung Neoplasms (Lung Cancer) 09/2005

Drug/Important Bio-Agent (IBA)

7	Hormones (Hormone)IBA 04/2022 - 09/2011
4	Estrogen ReceptorsIBA 01/2021 - 01/2018
3	Protons (Proton)IBA 12/2021 - 05/2016
3	Estrogens (Estrogen)FDA Link 01/2021 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2019
2	Riluzole FDA LinkGeneric 04/2019 - 04/2011
2	Glutamic Acid (Glutamate)FDA Link 04/2019 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 01/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	PlatinumIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Aromatase InhibitorsIBA 07/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	metabotropic glutamate receptor 3 (mGluR3)IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2018
1	AnthracyclinesIBA 01/2014
1	TroponinIBA 01/2014
1	Tamoxifen FDA LinkGeneric 09/2013
1	pazopanib FDA Link 01/2012
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2011
1	Iodine-125IBA 03/2010
1	Palonosetron (Aloxi)FDA Link 01/2009
1	AntiemeticsIBA 01/2009
1	Yttrium-90IBA 01/2009

Therapy/Procedure

39	Radiotherapy 10/2022 - 04/2002
18	Therapeutics 01/2021 - 04/2002
15	Segmental Mastectomy (Lumpectomy) 12/2021 - 04/2002
12	Drug Therapy (Chemotherapy) 01/2022 - 09/2005
9	Brachytherapy 01/2019 - 11/2008
7	Mastectomy (Mammectomy) 12/2021 - 03/2014
4	Proton Therapy 10/2019 - 05/2016
3	Aftercare (After-Treatment) 10/2019 - 04/2011
2	Re-Irradiation 12/2021 - 07/2021
2	Adjuvant Chemotherapy 01/2021 - 12/2016
2	Adjuvant Radiotherapy 10/2012 - 01/2012
1	Immunotherapy 01/2020
1	Neoadjuvant Therapy 12/2018
1	Lasers (Laser) 06/2014
1	Laser Therapy (Surgery, Laser) 06/2014
1	Catheters 09/2009
1	Patient Readmission 01/2009
1	Chemoprevention 04/2002